Where do you start when looking for the best Mounjaro doctor in Degla Maadi?
If you are searching for the best Mounjaro doctor in Degla Maadi, turn the word “best” into questions you can verify. Will a qualified physician assess you? Will they review eligibility, contraindications and your medicines? Do they have a nutrition, monitoring, side-effect and exit plan rather than simply prescribing a pen? You can start with a medical assessment at La Rose with Dr Shimaa Fouad, a physician, clinical and therapeutic nutrition specialist, and ESPEN member, at the New Maadi branch: 14 El-Mokhtar Street, off El-Nasr Street, behind QNB Bank. The branch is about 2.6–3.6 km from Degla Square, or roughly 7–8 minutes by car depending on the route and traffic.
The purpose of the visit is to decide whether tirzepatide is suitable at all, not to guarantee a prescription. The doctor reviews your weight pattern, previous attempts, conditions and medicines, symptoms, pregnancy or pregnancy plans when relevant, and available test results. The resulting plan may be medicine alongside nutrition and activity, or a different route that fits better. Weight-management medicines work best within continuing dietary and behavioural care, and selection should be a decision between you and the clinician based on benefits, risks and your circumstances—not a brand name or somebody else's experience [3, 4, 7].
This guide focuses on choosing a doctor to start and supervise Mounjaro when you live in Degla: eligibility, tests when needed, food alongside treatment, follow-up rhythm, side-effect handling, and a stopping or maintenance plan. For the broad service and medicine-name overview, read Mounjaro and Wegovy in Maadi rather than repeating it here [1, 2, 3].
Seven questions for choosing a Mounjaro doctor near Degla
First question: who owns the medical decision? Choose a service where a physician reviews the diagnosis, medicines and risks and can explain why treatment is or is not appropriate. Second: does the assessment go beyond BMI? Weight, height and waist can help, but blood pressure, glucose, weight-related disease, eating, sleep, activity and previous attempts also matter. Third: are tests selected for your situation, or sold as one package for everyone? A good assessment begins with a clinical question and then chooses a test that could change the decision [3, 4, 6].
Fourth: where is the food plan? Reduced appetite may make smaller intake easier, but it can also leave protein, nutrients or fluid inadequate without guidance. Fifth: what does follow-up measure besides the scale? Ask about symptoms, ability to eat and drink, glucose if you have diabetes, waist, and body composition, strength or function when useful, as well as adherence. Sixth: if a symptom appears, how do you make contact and when is it urgent? Clear instructions should exist before treatment starts [1, 2, 10].
Seventh: what is the plan if the medicine does not help, is not tolerated, or it becomes time to discuss stopping? A responsible service does not guarantee an outcome, press you to intensify treatment simply because the scale moved slowly, or sell an unknown product. Safe programmes explain continuing support, risks, realistic limits and weight-maintenance planning. Avoid rapid promises, before-and-after images presented as though one person's result were a rule, and prescriptions without assessment [4, 8, 9].
The first visit: what should the doctor review before a Mounjaro decision?
Bring a list of every medicine and supplement, recent results, and reports concerning diabetes, blood pressure, kidneys, gallbladder, pancreas or digestion. Write down your weight history and previous attempts, whether appetite, emotional eating or sleep is a major factor, and whether you have repeated vomiting or a sense that food remains in your stomach for a long time. The doctor should also ask about allergies, a personal or family history of medullary thyroid carcinoma or MEN 2, diabetic retinopathy, and medicines such as insulin or a sulfonylurea because these can change the safety and monitoring plan [1, 2, 3].
The examination may include weight, height, BMI, waist and blood pressure, together with an assessment of how weight affects health and function. Tests are then individualised. Glucose or HbA1c, kidney or liver function, lipids, or other tests may be useful when the history, symptoms or accompanying medicines raise a question, but there is no fixed list for every person. Ultrasound is not automatically required before injections either. It is requested when there is a clinical question, such as abdominal symptoms or suspected liver or gallbladder disease, and it cannot guarantee that a future problem will not occur [1, 3, 6].
The guide to tests and ultrasound before Mounjaro or Wegovy explains what each test can answer and when ultrasound adds information, so this page does not duplicate it. The important point is that the doctor interprets results beside the history and examination and tells you what changes because of them: starting, delaying, choosing a different route or coordinating with another clinician. Ask for a copy of the plan, clear baseline measurements, and a route for contact if a symptom appears before review [4, 6, 13].
Who may discuss tirzepatide, and who needs another route?
Weight-management medicine is not intended for rapid cosmetic loss or a few kilograms without a health indication. As a common starting point in guidance and labels, adult discussion often begins at a BMI of 30 or above, or 27 or above with a weight-related condition, but the number alone is not a prescription. The clinician relates it to fat distribution and waist, glucose, blood pressure and lipids, activity and sleep, previous attempts and measurable health goals. They should also explain the distinction between the Mounjaro name used for diabetes in the US label and tirzepatide used for weight management under another brand there; actual use depends on the locally registered product and the prescriber's decision [1, 2, 3, 6].
Contraindications and warnings need an explicit review. The tirzepatide weight-management label contraindicates use with a personal or family history of medullary thyroid carcinoma or MEN 2, or a previous serious hypersensitivity reaction to the ingredient. Pregnancy is not a time to use treatment for weight loss, and pregnancy planning belongs in the decision from the beginning. Symptoms of severely delayed stomach emptying, a history of pancreatic or gallbladder problems, repeated dehydration, kidney disease, diabetic retinopathy, or medicines that lower glucose do not all carry the same decision, but they call for closer assessment, a monitoring plan or a different choice [1, 2, 3].
If you are asking who can take weight-loss injections, the dedicated article explains contraindications and caution situations. The choosing standard here is that the doctor should not turn a general list into your diagnosis or begin treatment before understanding the whole situation. The visit may appropriately lead to food and activity care without medicine, treatment of a contributing medical issue, or referral to another specialty. Do not start, stop or switch a medicine yourself [3, 8, 13].
Nutrition beside treatment: less appetite is not a complete plan
Tirzepatide affects appetite and satiety pathways, but reducing food quantity without a plan can reduce diet quality too. Before treatment, the doctor should understand your day: meals, protein sources, vegetables and fruit, grains and pulses, fluids, constipation or vomiting, emotional eating, work and sleep times, and activity. Good care does not give one fixed protein or fluid number to everyone. Needs are individualised for body size, kidney health, activity, age, conditions and gastrointestinal tolerance [3, 10].
The joint nutrition and obesity society advisory recommends nutritional assessment before treatment, a varied nutrient-dense diet, management of gastrointestinal effects, and attention to protein and resistance activity to help preserve muscle mass and function. In practice, this means smaller balanced meals when appetite is low, an appropriate protein source within meals according to the plan, fibre and fluid that suit you, and changes in texture or timing when nausea is present. A supplement is not automatic; evidence of a deficiency or a clinical concern should guide that decision [10].
A good doctor asks: can you eat and drink? Are vomiting or diarrhoea exposing you to dehydration? Is weakness or dizziness related to low intake, a diabetes medicine or something else? Is weight loss accompanied by worse strength or function? Follow-up may use weight, waist and body composition when useful, but those numbers are interpreted beside performance and food intake. The goal is sustainable health, not the lowest possible scale number at any cost [4, 7, 10].
Follow-up rhythm: what should be reviewed from one visit to the next?
There is no single visit frequency for everyone. Reviews are closer together early on or when the plan changes, depending on symptoms, conditions and medicines; after stability they may be spaced according to the clinician's decision. Before starting, agree when review will occur, how to make contact between visits, and which symptoms should not wait. NICE emphasises reviewing response, tolerability and dietary and activity support, and that any change or discontinuation is a clinical decision rather than a personal experiment [5, 13].
At each review, record nausea, vomiting, diarrhoea or constipation, abdominal pain, fluid and food intake, and energy. If you have diabetes or use insulin or a sulfonylurea, a glucose-monitoring plan and review of diabetes medicines matter because combined treatment may increase hypoglycaemia risk. Review blood pressure where relevant, the trend in weight and waist, ability to move or exercise, and how workable the food plan has been. A scale that stays level for one week is not an automatic reason to change treatment; the longer trend, health, tolerability and adherence matter more [1, 2, 3, 10].
Responsible follow-up asks whether health benefit continues and whether side effects or treatment burden now outweigh it. The doctor may continue the plan, modify it or choose another route, but do not change or make up a dose yourself. Keep the product and ingredient name, concentration, a photograph of the package, dates of use and symptoms so decisions rely on clear information. An unknown or unapproved product has not undergone the same review for quality, safety and effectiveness [5, 8, 9].
The side-effect plan: when do you contact the doctor or seek emergency care?
Nausea, diarrhoea, vomiting, constipation and abdominal pain are recognised effects with tirzepatide and are often more noticeable during periods of treatment change. Before starting, the plan should tell you to record severity and duration, ability to eat and drink, urination and dizziness, and when to make contact. A common symptom should not simply be left alone; continuing vomiting or diarrhoea can cause dehydration and affect kidney function, especially when another risk factor is present [1, 2, 10].
Severe persistent abdominal pain, particularly if it travels to the back and occurs with or without vomiting, needs urgent assessment for possible pancreatitis. Upper abdominal pain with fever or yellowing of the skin or eyes may indicate a gallbladder problem. Trouble breathing, swelling of the face or tongue, fainting or a severe allergic reaction requires immediate emergency care. Reduced urination, marked dizziness or inability to keep fluids down calls for prompt medical contact and may need urgent assessment depending on severity [1, 2].
Shaking, sweating, palpitations, dizziness or confusion in someone using diabetes medicines may represent low glucose and calls for the clinician's agreed action plan. A sudden vision change, severe or persistent stomach symptoms, or a neck lump, hoarseness or difficulty swallowing should be reported. The guide to serious side effects of Mounjaro and Wegovy provides fuller triage, so keep it as a reference and do not stop or restart treatment yourself. Choosing a good doctor means this response plan exists in writing before a problem [1, 2, 3].
Stopping and weight-maintenance planning begins before the first prescription
Ask at the first visit: how will benefit be judged, when will the plan be reassessed, and what happens if side effects prevent continuation or a health goal is reached? Obesity is a chronic disease, and medicine is not a short course with one ending that suits everyone. Continuing or stopping depends on health benefit, tolerability, associated conditions, ability to follow the plan and your preferences after discussion with the clinician. Do not choose a stopping date or reduction method yourself [3, 5, 13].
The randomised SURMOUNT-4 trial studied adults with obesity or overweight and a weight-related complication. Withdrawing tirzepatide after the initial treatment period was associated with substantial regain of lost weight, while continued treatment maintained and augmented weight reduction on average. That is a group result under defined research conditions, not a prediction of your outcome, but it is a strong reason not to leave post-treatment planning until the end [11].
A practical plan includes an eating pattern you can continue, suitable sources of protein and nutrients, movement and resistance activity according to ability, balanced monitoring of weight or waist, and a clear next step if hunger or weight begins to return. NICE suggests a higher level of food and activity support after regain, with reassessment of medical options when needed. If medicine does not provide enough benefit or side effects outweigh it, the clinician reviews causes and alternatives; the answer is not to intensify or stop abruptly by yourself [4, 5, 10, 11].
Follow-up options for Degla residents: rank them on medical criteria
The first practical option is a nearby service with a named physician and specialty, assessment before prescribing, clinical nutrition, measurements and clear follow-up. At La Rose Maadi, Dr Shimaa Fouad follows clinical nutrition and weight management, and the branch has consultations, InBody, ultrasound and body-contouring services in one place. Each service is used when appropriate to the plan; ultrasound is not an automatic procedure before injections. Proximity to Degla can make reviews easier to attend, but it does not replace the quality of medical decisions [4, 6, 10].
A second option may be a hospital-based obesity or medical-nutrition clinic that can coordinate with diabetes or internal medicine when your case is complex. A third is a university-hospital outpatient clinic if several conditions or specialties are involved. A bariatric surgical opinion is appropriate when the doctor finds that referral criteria may apply, not simply because an injection did not produce rapid loss. A responsible service can say that treatment is unsuitable and explain an alternative or referral [3, 13].
Directory reviews may tell you about waiting or booking convenience, but they do not establish prescribing quality on their own. Check the clinician's qualification, who responds to symptoms, whether measurements and tests are interpreted, and whether food and maintenance plans exist. Treat a guaranteed result, medicine sold inside an unclear package, or pressure to start without a medical history as a reason to pause. If prescribed, the product is obtained with a prescription from a licensed pharmacy; a social-media source is not a substitute [4, 8, 9].
From Degla Square to the Maadi branch: route and booking
From Degla Square to La Rose Maadi, the Google Maps measured distance is about 2.6–3.6 km and the usual drive is roughly 7–8 minutes depending on the route; traffic can change it. The address is 14 El-Mokhtar Street, off El-Nasr Street, directly behind QNB Bank, New Maadi, Cairo. Dr Shimaa Fouad is at the Maadi branch on Saturday, Monday and Tuesday from 3 to 8 pm.
To book or ask about the visit cost, call or send a WhatsApp message to 010 4066 1893, and the team will tell you the details before you book. Schedules can change, so confirm the day and time when booking. Before travelling, prepare your medicine and supplement list, recent results and reports, weight history, and any digestive symptoms or pregnancy plans that apply. If you already use a product, bring the package or a clear photograph showing its name, concentration and source.
If you have severe persistent abdominal pain, trouble breathing, swelling of the face or tongue, fainting, or continuing vomiting that prevents fluid intake, do not wait for a clinic appointment; seek emergency care [1, 2]. For a non-urgent concern and a starting and follow-up assessment near Degla, Book at the Maadi branch, and make your first question at the visit: “What is the complete plan before, during and after medicine?” [3, 4].
